iCAD is a provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. The Company offers a comprehensive range of high-performance, upgradeable CAD solutions for mammography and advanced image analysis and workflow solutions for Magnetic Resonance Imaging, for breast and prostate cancers and Computed Tomography for colorectal cancer. iCAD’s Xoft System offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. The Xoft System is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer.
Type
Public
HQ
Nashua, US
Size (employees)
116 (est)
icad is headquartered in Nashua, US
Report incorrect company information

Key People/Management at icad

Ken Ferry

Ken Ferry

CEO
Stacey Stevens

Stacey Stevens

Executive Vice President, Chief Strategy and Commercial Officer
Jonathan Go

Jonathan Go

Senior Vice President of Research & Development

icad Office Locations

icad has offices in Nashua and San Jose
Nashua, US (HQ)
98 Spit Brook Rd
San Jose, US
101 Nicholson Ln
Show all (2)
Report incorrect company information

icad Financials and Metrics

icad Financials

icad's revenue was reported to be $26.34 m in FY, 2016 which is a 36.6% decrease from the previous period.
USD

Revenue (Q1, 2018)

6.3 m

Gross profit (Q1, 2018)

4.5 m

Gross profit margin (Q1, 2018), %

71.2%

EBIT (Q1, 2018)

(3.1 m)

Market capitalization (22-Jun-2018)

53.3 m

Closing share price (22-Jun-2018)

3.2

Cash (31-Mar-2018)

8.7 m
icad's current market capitalization is $53.3 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

5.6 m43.9 m41.6 m26.3 m

Revenue growth, %

684%(5%)(37%)

Cost of goods sold

10 m12.7 m12.2 m7.8 m

Gross profit

(4.4 m)31.2 m29.4 m18.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

8.3 m8.5 m9.7 m12.6 m13.2 m11.1 m9.6 m6 b7.4 m6 m6.8 m6.4 m7 m6.3 m

Cost of goods sold

2.4 m2.6 m2.8 m3.4 m3.9 m3.3 m2.8 m1.9 b1.7 m1.9 m2.1 m1.9 m2.4 m1.8 m

Gross profit

5.9 m5.9 m6.8 m9.2 m9.4 m7.9 m6.8 m4.2 b5.7 m4.1 m4.7 m4.5 m4.6 m4.5 m

Gross profit Margin, %

71%70%71%73%71%71%71%69%77%68%69%70%66%71%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

11.9 m32.2 m15.3 m8.6 m

Inventories

649 k540 k684 k3.7 m

Current Assets

22 m44.6 m27.8 m19.9 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

10.2 m38.4 m34.9 m33.4 m20.3 m18.2 m17.5 m12.9 m11.5 m10.5 m9.5 m7.7 m11.3 m8.7 m

Accounts Receivable

(2.1 m)

Inventories

2 m2 m1.9 m2 m2.7 m3.3 m3.7 m4.5 m4.5 m4.4 m3.5 m3.5 m3.3 m2.2 m

Current Assets

21.3 m48.5 m46.8 m47.2 m33.9 m29.7 m30.4 m23.9 m23.1 m20.8 m19.3 m17.1 m22.7 m19.3 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(7.6 m)(1 m)(32.4 m)(10.1 m)

Depreciation and Amortization

706 k1.3 m1.6 m1.3 m

Inventories

228 k(323 k)(2 m)596 k

Accounts Payable

60 k150 k(557 k)(16 k)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(3.3 m)

Depreciation and Amortization

527 k639 k188 k

Inventories

(72 k)

Accounts Payable

2 m1.8 m2.2 m1.8 m1.6 m1.6 m1.5 m1.3 m1.7 m177 k
USDY, 2018

Financial Leverage

2.6 x
Show all financial metrics
Report incorrect company information

icad Online and Social Media Presence

Embed Graph
Report incorrect company information